FDANonrulemakingFDA-2022-D-2870

Who commented on this docket

Decentralized Clinical Trials for Drugs, Biological Products, and Devices; Draft Guidance for Industry, Investigators, and Other Stakeholders; Availability

1 organizations filed 1 public comment on Decentralized Clinical Trials for Drugs, Biological Products, and Devices; Draft Guidance for Industry, Investigators, and Other Stakeholders; Availability, at the Food and Drug Administration. The comment window closed 1092d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 1092d ago

Abstract

OPEN

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.